Alnylam Pharmaceuticals Overview
Alnylam Pharmaceuticals Discounted Cash Flow
DCF Analysis for ALNY.
Get informed when a big investor buys or sells
+ FollowFair Value
$160.69
Current Fair Value
$160.69
↓ 42.2% Downside
Overvalued by 42.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison